• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胱抑素C在川崎病合并冠状动脉瘤中的价值。

Value of cystatin C for Kawasaki disease with coronary artery aneurysm.

作者信息

Liang Kaizhi, Su Danyan, Pang Yusheng

机构信息

Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

出版信息

Transl Pediatr. 2025 Apr 30;14(4):545-558. doi: 10.21037/tp-2024-516. Epub 2025 Apr 27.

DOI:10.21037/tp-2024-516
PMID:40386375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12079684/
Abstract

BACKGROUND

Cardiovascular and kidney diseases are interconnected through shared biological mechanisms. However, research on renal function in Kawasaki disease (KD) remains insufficient. This study focused on coronary artery aneurysm (CAA), a severe cardiac consequence of KD, aiming to examine the predictive value of cystatin C (Cys C) and other common laboratory indicators before and after intravenous immunoglobulin (IVIG) treatment on KD with CAA.

METHODS

Based on patients' coronary status, 122 KD individuals were categorized in this retrospective analysis. After comparing the clinical and laboratory information of the patients with KD, multivariate logistic regression analysis was employed to identify independent risk factors for CAA development among them. Additionally, the predictive values of these parameters in CAA development of KD were assessed by receiver operating characteristic (ROC) curves.

RESULTS

In this study, 28 patients (23.0%, 28/122) had CAA, including 12 who had coronary artery regression (9.8%, 12/122). The parameters with P<0.10 in the difference analysis, namely polymorphous exanthem, changes in the extremities, plateletocrit and Cys C before IVIG, prealbumin >107.2 mg/L and prognostic nutritional index >54.7 after IVIG, were included in multivariate logistic regression analysis. Finally, binary logistic regression analysis identified the pre-IVIG Cys C [odds ratio, 10.183; 95% confidence interval (CI): 1.158-89.525] as an independent risk factor for developing CAA among KD patients. In addition, the 0.71 Cys C cut-off value sampled within five days had a 100% sensitivity and a 42.9% specificity (area under the ROC curve =0.752, 95% CI: 0.577-0.928, P=0.03).

CONCLUSIONS

Higher pre-IVIG Cys C levels may be associated with increased CAA risk, but further large-scale prospective studies are needed to confirm its predictive utility. Furthermore, Cys C acquired within five days of disease onset may theoretically provide better prediction power for the CAA development in KD.

摘要

背景

心血管疾病和肾脏疾病通过共同的生物学机制相互关联。然而,关于川崎病(KD)肾功能的研究仍然不足。本研究聚焦于KD的严重心脏后果——冠状动脉瘤(CAA),旨在探讨胱抑素C(Cys C)及其他常见实验室指标在静脉注射免疫球蛋白(IVIG)治疗前后对合并CAA的KD的预测价值。

方法

在这项回顾性分析中,根据患者的冠状动脉状况对122例KD患者进行分类。比较KD患者的临床和实验室信息后,采用多因素逻辑回归分析确定其中CAA发生的独立危险因素。此外,通过受试者工作特征(ROC)曲线评估这些参数在KD患者CAA发生中的预测价值。

结果

在本研究中,28例患者(23.0%,28/122)患有CAA,其中12例出现冠状动脉退缩(9.8%,12/122)。差异分析中P<0.10的参数,即多形性皮疹、四肢变化、IVIG治疗前的血小板压积和Cys C、IVIG治疗后前白蛋白>107.2 mg/L以及预后营养指数>54.7,被纳入多因素逻辑回归分析。最后,二元逻辑回归分析确定IVIG治疗前的Cys C[比值比,10.183;95%置信区间(CI):1.158 - 89.525]是KD患者发生CAA的独立危险因素。此外,发病五天内采集的Cys C临界值为0.71时,敏感性为100%,特异性为42.9%(ROC曲线下面积 = 0.752,95%CI:0.577 - 0.928,P = 0.03)。

结论

IVIG治疗前较高的Cys C水平可能与CAA风险增加有关,但需要进一步的大规模前瞻性研究来证实其预测效用。此外,在疾病发作五天内获取的Cys C理论上可能为KD患者CAA的发生提供更好的预测能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84c/12079684/92c922bea74c/tp-14-04-545-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84c/12079684/2c45e1c7b28f/tp-14-04-545-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84c/12079684/7f988bbafa19/tp-14-04-545-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84c/12079684/92c922bea74c/tp-14-04-545-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84c/12079684/2c45e1c7b28f/tp-14-04-545-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84c/12079684/7f988bbafa19/tp-14-04-545-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84c/12079684/92c922bea74c/tp-14-04-545-f3.jpg

相似文献

1
Value of cystatin C for Kawasaki disease with coronary artery aneurysm.胱抑素C在川崎病合并冠状动脉瘤中的价值。
Transl Pediatr. 2025 Apr 30;14(4):545-558. doi: 10.21037/tp-2024-516. Epub 2025 Apr 27.
2
Prognostic nutritional index value in the prognosis of Kawasaki disease with coronary artery lesions.川崎病合并冠状动脉病变预后中的预后营养指数值
Front Nutr. 2023 Feb 1;10:1075619. doi: 10.3389/fnut.2023.1075619. eCollection 2023.
3
Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.治疗前后川崎病患者静脉注射免疫球蛋白抵抗和冠状动脉瘤的实验室预测因子评估。
Clin Rheumatol. 2023 Jan;42(1):167-177. doi: 10.1007/s10067-022-06366-x. Epub 2022 Sep 21.
4
Risk Factors for Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Abnormalities in a Chinese Pediatric Population With Kawasaki Disease: A Retrospective Cohort Study.中国川崎病儿科人群中静脉注射免疫球蛋白治疗抵抗和冠状动脉异常的危险因素:一项回顾性队列研究
Front Pediatr. 2022 Apr 20;10:812644. doi: 10.3389/fped.2022.812644. eCollection 2022.
5
Risk factors and coronary artery outcomes of coronary artery aneurysms differing in size and emergence time in children with Kawasaki disease.川崎病患儿不同大小和出现时间的冠状动脉瘤的危险因素及冠状动脉结局
Front Cardiovasc Med. 2022 Sep 9;9:969495. doi: 10.3389/fcvm.2022.969495. eCollection 2022.
6
Prognostic nutrition index as a predictor of coronary artery aneurysm in Kawasaki Disease.预后营养指数作为川崎病冠状动脉瘤的预测指标
BMC Pediatr. 2020 May 11;20(1):203. doi: 10.1186/s12887-020-02111-y.
7
A practical nomogram for predicting coronary thrombosis for Kawasaki disease patients with medium or large coronary artery aneurysm.用于预测伴有中等或大型冠状动脉瘤的川崎病患者冠状动脉血栓形成的实用列线图。
Clin Exp Med. 2023 Aug;23(4):1317-1324. doi: 10.1007/s10238-022-00893-2. Epub 2022 Sep 23.
8
Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.单核细胞/高密度脂蛋白胆固醇比值对川崎病冠状动脉病变及静脉用免疫球蛋白抵抗的预测价值。
Eur J Pediatr. 2023 Oct;182(10):4399-4406. doi: 10.1007/s00431-023-05122-w. Epub 2023 Jul 22.
9
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.川崎病冠状动脉瘤:美国人群中进展性疾病和不良心脏事件的危险因素。
J Am Heart Assoc. 2016 Sep 15;5(9):e003289. doi: 10.1161/JAHA.116.003289.
10
Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.川崎病患者静脉注射免疫球蛋白抵抗及冠状动脉瘤的预测因素
Paediatr Int Child Health. 2018 Aug;38(3):209-212. doi: 10.1080/20469047.2018.1471381. Epub 2018 May 17.

本文引用的文献

1
Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association.川崎病诊断与管理的最新进展:美国心脏协会的科学声明
Circulation. 2024 Dec 3;150(23):e481-e500. doi: 10.1161/CIR.0000000000001295. Epub 2024 Nov 13.
2
Plasma Protein Biomarkers and Long-Term Cardiovascular Mortality Risk in Patients With Chronic Coronary Heart Disease.血浆蛋白生物标志物与慢性冠心病患者的长期心血管死亡率风险。
J Am Heart Assoc. 2024 Nov 5;13(21):e034367. doi: 10.1161/JAHA.123.034367. Epub 2024 Oct 25.
3
Risk factors and scores for prediction of coronary artery aneurysms in Kawasaki disease: a European monocentric study.
川崎病冠状动脉瘤预测的危险因素和评分:一项欧洲单中心研究。
BMC Pediatr. 2024 Feb 23;24(1):139. doi: 10.1186/s12887-024-04623-3.
4
Therapeutic plasma exchange for refractory Kawasaki disease in children weighing less than 10 kg.对于体重小于 10kg 的儿童难治性川崎病,采用治疗性血浆置换。
Ther Apher Dial. 2024 Jun;28(3):424-431. doi: 10.1111/1744-9987.14099. Epub 2023 Dec 14.
5
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association.心血管-肾脏-代谢(CKM)综合征的科学证据和临床管理概要:美国心脏协会的科学声明
Circulation. 2023 Nov 14;148(20):1636-1664. doi: 10.1161/CIR.0000000000001186. Epub 2023 Oct 9.
6
polymorphism (rs7251246 T > C), coronary artery aneurysms, and thrombosis in patients with Kawasaki disease in a Southern Han Chinese population.在南方汉族人群中,川崎病患者的多态性(rs7251246 T > C)、冠状动脉瘤和血栓形成。
Front Immunol. 2023 Jun 19;14:1184162. doi: 10.3389/fimmu.2023.1184162. eCollection 2023.
7
The incidence of Kawasaki disease using hospital admissions data for England 2006-2021.2006-2021 年英格兰基于医院入院数据的川崎病发病率。
Rheumatology (Oxford). 2023 Sep 1;62(9):3117-3125. doi: 10.1093/rheumatology/kead051.
8
Clinical Characteristics and Prognosis of Patients with Multi-Vessel Coronary Spasm in Comparison with Those in Patients with Single-Vessel Coronary Spasm.多支冠状动脉痉挛患者与单支冠状动脉痉挛患者的临床特征及预后比较
J Cardiovasc Dev Dis. 2022 Jun 28;9(7):204. doi: 10.3390/jcdd9070204.
9
Analysis of the Risk Factors in Prognosis of Kawasaki Disease With Coronary Artery Lesions.川崎病合并冠状动脉病变预后的危险因素分析
Front Pediatr. 2021 Dec 7;9:798148. doi: 10.3389/fped.2021.798148. eCollection 2021.
10
Global epidemiology of vasculitis.血管炎的全球流行病学。
Nat Rev Rheumatol. 2022 Jan;18(1):22-34. doi: 10.1038/s41584-021-00718-8. Epub 2021 Dec 1.